GBIO vs JAZZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

GBIO

42.9
AI Score
VS
GBIO Wins

JAZZ

30.5
AI Score

Investment Advisor Scores

GBIO

43score
Recommendation
HOLD

JAZZ

31score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric GBIO JAZZ Winner
Forward P/E 7.874 10.0402 GBIO
PEG Ratio 0 0.9582 Tie
Revenue Growth -78.9% 10.4% JAZZ
Earnings Growth 0.0% 3.2% JAZZ
Tradestie Score 42.9/100 30.5/100 GBIO
Profit Margin 0.0% 4.4% JAZZ
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY GBIO

Relative Price Performance (Last 90 Days)

GBIO 1M: -2.4% · 3M: +1.7% JAZZ 1M: +18.0% · 3M: +1.0%

Current Technical Phase

GBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 39.7 · Price: $5.34

JAZZ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 68

RSI (14): 67.9 · Price: $248.24

Fundamentals Snapshot

Metric GBIO JAZZ
Market Cap — —
Forward P/E -0.7 9.6
Trailing P/E — 72.6
Revenue (TTM) — —
Revenue Growth -0.8% 0.1%
Gross Margin -2.1% 0.9%
Operating Margin -20.2% 0.3%
EPS -9.37 3.38
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.